123 related articles for article (PubMed ID: 20686230)
1. TJN-331 improves anti-glomerular basement membrane nephritis by inhibiting the production of intraglomerular transforming growth factor-beta1.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(8):1349-54. PubMed ID: 20686230
[TBL] [Abstract][Full Text] [Related]
2. Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-β1 production.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Kase Y; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(10):1710-5. PubMed ID: 20930380
[TBL] [Abstract][Full Text] [Related]
3. (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Takeda S; Takeda H; Hattori T
Clin Exp Nephrol; 2010 Dec; 14(6):528-35. PubMed ID: 20814808
[TBL] [Abstract][Full Text] [Related]
4. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.
Sadakane C; Kase Y; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Clin Exp Nephrol; 2011 Feb; 15(1):14-24. PubMed ID: 20820840
[TBL] [Abstract][Full Text] [Related]
5. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
Sadakane C; Hattori T; Koseki J; Inagaki Y; Hasegawa Y; Shindo S; Takeda S; Takeda H
Biol Pharm Bull; 2009 Oct; 32(10):1728-33. PubMed ID: 19801835
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
7. Modulation of anti-glomerular basement membrane nephritis in rats by ONO-1301, a non-prostanoid prostaglandin I2 mimetic compound with inhibitory activity against thromboxane A2 synthase.
Hayashi K; Nagamatsu T; Oka T; Suzuki Y
Jpn J Pharmacol; 1997 Jan; 73(1):73-82. PubMed ID: 9032136
[TBL] [Abstract][Full Text] [Related]
8. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
10. Immunoelectron microscopic study on type I, II and III TGF-beta receptors on visceral glomerular epithelial cells in relation to glomerular basement membrane alterations in proteinuric rats.
Fujigaki Y; Watanabe T; Ikegaya N; Yonemura K; Sun DF; Hishida A; Yamamoto T; Kojima K; Nagase M
Nephrol Dial Transplant; 2000 Feb; 15(2):191-9. PubMed ID: 10648664
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats.
Fujigaki Y; Sun DF; Fujimoto T; Yonemura K; Morioka T; Yaoita E; Hishida A
Virchows Arch; 2001 Jul; 439(1):35-45. PubMed ID: 11499838
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy.
Hruby Z; Wendycz D; Kopeć W; Zieliński B; Paczek L; Soin J
Res Exp Med (Berl); 2000 Apr; 199(5):295-307. PubMed ID: 10815758
[TBL] [Abstract][Full Text] [Related]
13. Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.
Datta PK; Reddy RS; Lianos EA
Inflammation; 2001 Dec; 25(6):351-9. PubMed ID: 11831438
[TBL] [Abstract][Full Text] [Related]
14. Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.
Fukuda A; Minakawa A; Sato Y; Iwakiri T; Iwatsubo S; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2017 Nov; 32(11):1818-1830. PubMed ID: 28419296
[TBL] [Abstract][Full Text] [Related]
15. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
Haraguchi M; Border WA; Huang Y; Noble NA
Kidney Int; 2001 Jun; 59(6):2146-55. PubMed ID: 11380816
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
18. Acetoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent: effect of acteoside on crescentic-type anti-GBM nephritis in rats.
Hayashi K; Nagamatsu T; Ito M; Hattori T; Suzuki Y
Jpn J Pharmacol; 1994 Jun; 65(2):143-51. PubMed ID: 7526020
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental crescentic-type anti-glomerular basement membrane (GBM) nephritis by FK506 (tacrolimus hydrate) in rats.
Hayashi K; Nagamatsu T; Ito M; Suzuki Y
Jpn J Pharmacol; 1996 Jan; 70(1):43-54. PubMed ID: 8822088
[TBL] [Abstract][Full Text] [Related]
20. Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2).
Hattori T; Furuta K; Hayashi K; Nagamatsu T; Ito M; Suzuki Y
Jpn J Pharmacol; 1992 Nov; 60(3):187-95. PubMed ID: 1491511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
